Knoll Capital Management, LLC

13F Portfolio Filings

Most recent 13F
Q4 2023
Location
Miami, FL
CIK
0001325083
Alternate names
Knoll Capital Management, LP
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q4 2023 32 120,759 Biohaven Pharmactl Hldg Co L, ALDX, APLT, AVDL 13F-HR 2/14/2024 000110465924023617
Q3 2023 37 96,336 ALDX, APLT, Biohaven Pharmactl Hldg Co L, AVDL 13F-HR 11/14/2023 000110465923118123
Q2 2023 27 82,489 ALDX, Biohaven Pharmactl Hldg Co L, AVDL, HOOK 13F-HR 8/15/2023 000110465923091702
Q1 2023 26 64,886 ALDX, Biohaven Pharmactl Hldg Co L, AVDL calls, I9SA.HA 13F-HR 5/15/2023 000110465923060827
Q4 2022 21 44,310 ALDX, Biohaven Pharmactl Hldg Co L, ALT, GDX 13F-HR 2/14/2023 000110465923021561
Q3 2022 33 171,139 Biohaven Pharmactl Hldg Co L, ALDX, ENTX, ALT 13F-HR 11/14/2022 000110465922118490
Q2 2022 41 175,205 Biohaven Pharmactl Hldg Co L, ALDX, EIGR, ENTX 13F-HR 8/15/2022 000110465922091332
Q1 2022 41 159,335 Biohaven Pharmactl Hldg Co L, ENTX, EIGR, Orgenesis, Inc. 13F-HR 5/16/2022 000110465922061328
Q4 2021 38 181,975 Biohaven Pharmactl Hldg Co L, APLT, ENTX, Orgenesis, Inc. 13F-HR 2/14/2022 000110465922022678
Q3 2021 40 200,528 Biohaven Pharmactl Hldg Co L, APLT, ENTX, Orgenesis, Inc. 13F-HR 11/15/2021 000110465921139144
Q2 2021 42 191,496 Biohaven Pharmactl Hldg Co L, APLT, ENTX, CRBP 13F-HR 8/16/2021 000110465921106284
Q1 2021 39 153,492 Biohaven Pharmactl Hldg Co L, APLT, CRBP, Orgenesis, Inc. 13F-HR 6/14/2021 000110465921080656
Q4 2020 31 146,681 Biohaven Pharmactl Hldg Co L, APLT, EIGR, CRBP 13F-HR 2/16/2021 000110465921023937
Q3 2020 30 122,030 Biohaven Pharmactl Hldg Co L, APLT, CRBP, Orgenesis, Inc. 13F-HR 11/16/2020 000110465920125804
Q2 2020 19 173,219 Biohaven Pharmactl Hldg Co L, CRBP, APLT, ABEO 13F-HR 8/14/2020 000110465920095528
Q1 2020 18 106,461 Biohaven Pharmactl Hldg Co L, CRBP, APLT, ABEO 13F-HR 5/15/2020 000110465920062559
Q4 2019 18 135,430 Biohaven Pharmactl Hldg Co L, CRBP, APLT, ABEO 13F-HR 2/14/2020 000110465920022015
Q3 2019 23 109,262 Biohaven Pharmactl Hldg Co L, CRBP, BX, ABEO 13F-HR 11/14/2019 000110465919064196
Q2 2019 22 122,151 CRBP, Biohaven Pharmactl Hldg Co L, ABEO, BX 13F-HR 8/14/2019 000114420419040043
Q1 2019 17 131,596 Biohaven Pharmactl Hldg Co L, CRBP, ABEO, KRYS 13F-HR 5/15/2019 000114420419026565
Q4 2018 15 87,900 Biohaven Pharmactl Hldg Co L, CRBP, ABEO, KRYS 13F-HR 2/14/2019 000114420419008236
Q3 2018 17 118,296 CRBP, ABEO, Biohaven Pharmactl Hldg Co L, ALDX 13F-HR 11/14/2018 000114420418059931
Q2 2018 19 117,674 ABEO, Biohaven Pharmactl Hldg Co L, CRBP, ECOR 13F-HR 8/14/2018 000114420418044640
Q1 2018 13 97,391 ABEO, CRBP, Biohaven Pharmactl Hldg Co L, AMPE 13F-HR 5/15/2018 000114420418028860
Q4 2017 12 113,433 ABEO, CRBP, Biohaven Pharmactl Hldg Co L, AMPE 13F-HR 2/14/2018 000114420418008909
Q3 2017 16 116,948 ABEO, Biohaven Pharmactl Hldg Co L, CRBP, VBLT 13F-HR 11/14/2017 000114420417059028
Q2 2017 15 75,436 CRBP, Biohaven Pharmactl Hldg Co L, ABEO, AVXL 13F-HR 8/14/2017 000114420417043190
Q1 2017 17 66,328 CRBP, ABEO, VBLT, AVXL 13F-HR 5/15/2017 000114420417027485
Q4 2016 17 56,996 CRBP, ABEO, VBLT, AVXL 13F-HR 2/14/2017 000114420417008952
Q3 2016 18 57,031 CRBP, ABEO, SYN, VBLT 13F-HR 11/14/2016 000114420416134459
Q2 2016 22 308,530 MDVN, CRBP, SYN, ARCT 13F-HR 8/15/2016 000114420416119396
Q1 2016 22 246,277 MDVN, SYN, AMPE, CRBP 13F-HR 5/16/2016 000114420416102574
Q4 2015 21 269,729 MDVN, AMPE, SYN, ARCT 13F-HR 2/17/2016 000114420416083000
Q3 2015 19 235,563 MDVN, AMPE, SYN, ARCT 13F-HR 11/16/2015 000114420415066011
Q2 2015 19 310,193 MDVN, SYN, AMPE, Advaxis Inc. 13F-HR 8/14/2015 000114420415049867
Q1 2015 17 343,460 MDVN, AMPE, SYN, ARCT 13F-HR 5/15/2015 000114420415031597
Q4 2014 14 254,119 MDVN, AMPE, SYN, ARCT 13F-HR 2/17/2015 000114420415010045
Q3 2014 1 2,458 Bio Blast Pharma Ltd NEW HOLDINGS 12/9/2014 000114420414072900
Q3 2014 14 254,617 MDVN, AMPE, ARCT, KERX 13F-HR 11/14/2014 000114420414068774
Q2 2014 15 224,399 MDVN, AMPE, ARCT, KERX 13F-HR 8/14/2014 000114420414050192
Q1 2014 16 193,229 MDVN, AMPE, ARCT, SYN 13F-HR 5/15/2014 000114420414031318
Q4 2013 14 198,576 MDVN, AMPE, ARCT, KERX 13F-HR 2/14/2014 000114420414009812